Search the Osteosarcoma Now Clinical Trial Explorer

We attended the 2022 CTOS annual meeting. The meeting brought together clinicians, researchers and patient advocates dedicated to improving outcomes in sarcoma.

Surgeons may remove bone containing osteosarcoma and replace it with a metal implant. A study looked at whether carbon-fibre could be an alternative to metal.

There is an urgent need to find new therapies in osteosarcoma (OS) that has spread or has not responded to standard treatment. Identifying new treatments can be a long and complex process. One method of speeding up the process is to use drugs that already approved to...

There is a great need to develop new treatments for osteosarcoma (OS). This is particularly true for OS that has spread or has not responded to current standard therapy. Researchers are actively working towards finding new drugs to treat OS. To enable the drug...

The first ever global survey for bone cancerA disease where cells divide and grow uncontrollably and can spread to other areas of the body. More patients and carers has been launched. The aim of the survey is to advance research into bone cancer.

Surgeons are developing new techniques to aid them in removing bone cancer. One of these techniques is printing personalised 3D models of tumours to guide the surgery.

This October clinicians, researchers and patient advocates from across Europe came together for the first in-person FOSTER (Fighting OSteosarcoma Through European Research) meeting. The event was held over two days at the Gustave Roussy Cancer Research hospital in...

In September 2022, we attended the Immuno UK conference. Held over 2 days in London, UK, this conference brought together over 260 people from industry and academic research. We heard the latest updates in the field of “immune oncology”. This can be described as...

Being diagnosed with cancer can feel isolating. Bone Sarcoma Peer Support is a charity dedicated to connecting patients with shared experiences of bone cancer.

A study has identified a new possible drug target to treat osteosarcoma. The research is in its early stages but it shows that our understanding of osteosarcoma is increasing.